Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SLN Silence Therapeutics Plc - American Depository Share | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $10.93 +1.2% | $16.31 +6.3% |
| StockIQ Score | 41D Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 29F | 36F |
| Fundamental | 35F | 35F |
| Growth | 34F | 50C- |
| Fair Value | 38F | 38F |
| News | 98A+ | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Silence Therapeutics (SLN) and Ascentage Pharma (AAPG) both have "WEAK" ratings, but AAPG scores higher in growth (50 vs. 34), making it stronger in that category. SLN leads slightly in valuation (38 vs. 38, tied) and fundamental scores (both 35), while AAPG outperforms in technicals (36 vs. 29). Overall, AAPG shows more promise in growth potential.
